¿Primer pedido? Ahorra 20%.
(888) 510-7196
Volver
Caring SunshineIngredientes

Vitamin B9 (methylfolate/5-MTHF)

Condiciones de Salud29
Tabla de contenidos

Otros Nombres

(6S)-5-Methyltetrahydrofolate(6S)-5-Methyltetrahydrofolic acid(6S)-5-MTHF5-methyl-5,6,7,8-tetrahydrofolate5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid5-methyl-tetrahydrofolate5-methyl-THF5-Methyltetrahydrofolate5-Methyltetrahydrofolic acid5-Methyltetrahydropteroyl monoglutamate5-Methyltetrahydropteroylglutamate5-Methyltetrahydropteroylglutamic acid5-MTHFFolacinFolacineFolateL-5-MethyltetrahydrofolateL-5-Methyltetrahydrofolic acidL-5-MTHFL-methylfolateL. casei factorLevomefolic acidLevomefolinic acidmethyl-H4FMethylfolateN(5)-methyltetrahydrofolateN(5)-methyltetrahydrofolic acidN-MethyltetrahydrofolateN-Methyltetrahydrofolic acidN5-methyltetrahydrofolateN5-methyltetrahydrofolic acidN5-MethyltetrahydropteroylglutamatePrefolic APteroyl-L-glutamatePteroylglutamic acidPteroylmonoglutamic acidVitamin B9Vitamin BcVitamin M

Sinopsis

Historia

Cirsium oligophyllum, una especie de cardo nativa del este de Asia, tiene una rica historia en la medicina tradicional, especialmente dentro de las prácticas herbales chinas, japonesas y coreanas. Conocido por sus compuestos bioactivos, incluyendo flavonoides y saponinas, Cirsium oligophyllum ha sido valorado durante siglos como un remedio natural que aborda una amplia gama de dolencias.

Históricamente, las decocciones y extractos de Cirsium oligophyllum se empleaban comúnmente para promover la circulación sanguínea, reducir la inflamación y apoyar la salud hepática. Los curanderos tradicionales utilizaban esta planta para manejar los síntomas de los trastornos hemorrágicos, como la hemoptisis (expectoración de sangre), la epistaxis (hemorragia nasal), y la menstruación excesiva, atribuyéndole propiedades astringentes y hemostáticas. Además, la planta se aplicaba frecuentemente de forma externa para acelerar la cicatrización de heridas y aliviar la irritación cutánea.

En combinaciones herbales, Cirsium oligophyllum se empareja frecuentemente con otros botánicos para potenciar sus efectos terapéuticos. Las mezclas con Astragalus, Angelica y Rehmannia se usaban para fortalecer el sistema inmunológico y fomentar la vitalidad, mientras que las combinaciones con diente de león o cardo mariano tenían como objetivo amplificar las acciones desintoxicantes del hígado. Su sinergia con estas hierbas amplía su eficacia, convirtiéndola en un componente popular en los suplementos nutricionales modernos dirigidos a la salud circulatoria, el apoyo hepático y el bienestar general.

La investigación moderna continúa validando los usos tradicionales de Cirsium oligophyllum, destacando sus propiedades antioxidantes y antiinflamatorias. Sus acciones suaves pero efectivas la convierten en una valiosa adición a las formulaciones herbales contemporáneas, subrayando su relevancia duradera y sus contribuciones positivas a la salud holística.

Validación tradicional y científica

Cirsium oligophyllum es una especie de cardo nativa del este de Asia, utilizada tradicionalmente en la medicina popular por sus supuestos beneficios para la salud. Los registros históricos, particularmente de regiones como Japón y China, documentan el uso de diversas especies de Cirsium como remedios herbales para apoyar la salud hepática, ayudar a la digestión y promover el bienestar cardiovascular. Los extractos de las partes aéreas de la planta se han utilizado en tés, tinturas y preparaciones tópicas, valorados frecuentemente por sus propiedades antioxidantes y antiinflamatorias.

El interés científico moderno en Cirsium oligophyllum está creciendo, con varios estudios in vitro y en animales que sugieren que contiene compuestos bioactivos como flavonoides, saponinas y polifenoles. Se cree que estos constituyentes contribuyen a la actividad antioxidante de la planta, lo que puede ayudar a proteger las células del estrés oxidativo. La investigación preliminar también ha indicado posibles beneficios para el metabolismo lipídico y la salud vascular, aunque estos efectos se observan principalmente en entornos de laboratorio y modelos animales en lugar de en ensayos clínicos humanos a gran escala.

Si bien estos hallazgos tempranos son prometedores y apoyan los usos tradicionales de Cirsium oligophyllum, actualmente existe una falta de evidencia clínica sólida que confirme su eficacia en humanos. Se necesitan estudios mejor diseñados para validar sus beneficios y aclarar la dosificación óptima y la seguridad. No obstante, la importancia histórica de la planta y los datos científicos emergentes subrayan su potencial como un ingrediente valioso en productos nutricionales, lo que justifica una mayor exploración en el contexto del bienestar moderno y el apoyo a la salud.

Condiciones de Salud

Condiciones de salud que Vitamin B9 (methylfolate/5-MTHF) puede ayudar a apoyar.

  • DispepsiaCientífico

    5-Methyltetrahydrofolate (5-MTHF) is the bioactive circulating form of folate directly usable for DNA synthesis without requiring liver conversion. It corrects folate-deficiency megaloblastic anemia and is preferred in individuals with MTHFR polymorphisms impairing folic acid metabolism.

  • 5-Methyltetrahydrofolate (5-MTHF), the active form of folate, directly reduces homocysteine levels protecting arterial endothelium and improves endothelial NO availability. Unlike folic acid, 5-MTHF bypasses the MTHFR enzyme step, making it effective even in MTHFR polymorphism carriers who cannot efficiently convert folic acid. Clinical trials show improvements in FMD and reduction in PWV.

  • 5-Methyltetrahydrofolate (5-MTHF) is the bioactive, blood-brain-barrier-permeable form of folate, directly usable without hepatic conversion. It is especially important for individuals with MTHFR polymorphisms who cannot efficiently convert dietary folic acid. Supplementation with 5-MTHF corrects hyperhomocysteinemia, supports neurotransmitter synthesis, and addresses brain fog driven by folate deficiency or impaired folate metabolism.

  • Methylfolate (5-MTHF) is the bioactive form of folate increasingly used in celiac disease supplementation because it bypasses intestinal and hepatic conversion steps, making it particularly advantageous in patients with intestinal malabsorption. Folate deficiency is guideline-endorsed as a primary nutritional concern in CeD, and 5-MTHF specifically addresses the absorption challenges inherent to CeD gut damage.

  • 5-Methyltetrahydrofolate (5-MTHF/methylfolate) is an active, bioavailable form of folate increasingly used in children's MVMs, particularly for children with MTHFR gene variants who have reduced ability to convert folic acid. It bypasses the rate-limiting DHFR conversion step and provides folate directly in its biologically active form.

  • Methylfolate (5-MTHF) is the bioactive form of folate and bypasses MTHFR enzyme conversion, making it particularly relevant for individuals with MTHFR polymorphisms who often present with fatigue. It directly participates in methylation reactions and neurotransmitter synthesis. Clinical evidence supports superiority over folic acid in specific populations experiencing fatigue.

  • L-methylfolate (5-MTHF) is the bioavailable, active form of folate that directly supports monoamine neurotransmitter synthesis. It is FDA-approved as a prescription medical food (Deplin) for depression. RCTs show it significantly augments SSRI response in treatment-resistant depression, particularly in patients with MTHFR polymorphisms.

  • 5-MTHF (methylfolate) is the biologically active form of folate, bypassing the need for enzymatic conversion and providing more direct support for one-carbon metabolism, mitochondrial function, and red blood cell production. It addresses folate-deficiency-related fatigue, particularly in those with MTHFR genetic variants who cannot efficiently convert folic acid.

  • Methylfolate (5-MTHF) is the active bioavailable form of folate, bypassing the MTHFR enzyme and directly supporting DNA synthesis and methylation in spermatogenesis. Men with MTHFR polymorphisms (common in male infertility populations) may have impaired conversion of folic acid to 5-MTHF, and 5-MTHF supplementation can more effectively support sperm DNA integrity in these individuals.

  • 5-Methyltetrahydrofolate (5-MTHF) is the bioactive form of folate. In women with MTHFR gene variants (affecting 25–60% of the population), it bypasses impaired folic acid conversion, reducing homocysteine accumulation associated with recurrent pregnancy loss and supporting ovulatory function.

  • BronquitisCientífico

    Methylfolate (5-MTHF) is the active, directly bioavailable form of folate that does not require MTHFR enzyme conversion, making it especially important for adults with common MTHFR polymorphisms affecting ~40% of the population. It directly supports methylation reactions critical to epigenetic regulation, homocysteine reduction, and DNA integrity in aging.

  • 5-Methyltetrahydrofolate (5-MTHF/methylfolate) is the biologically active form of folate directly utilized in methionine synthesis and DNA methylation, critical for fetal neural tube development and growth. It bypasses the enzymatic conversion step impaired in individuals with MTHFR gene polymorphisms (a common genetic variant), making it particularly effective for ensuring adequate folate activity in at-risk pregnancies. Its role in preventing neural tube defects and supporting cell division underpins healthy fetal and infant growth.

  • BulimiaCientífico

    Methylfolate (5-MTHF) is the bioactive form of folate and shares the same hearing-health evidence as folic acid, particularly for homocysteine-mediated cochlear damage. Low folate status is significantly associated with age-related hearing loss, with optimal folate levels correlating with lower audiometric thresholds. A NHANES cross-sectional study confirmed this association.

  • Methylfolate (5-MTHF) is the bioactive form of folate that directly participates in homocysteine remethylation without requiring metabolic conversion by MTHFR. It is particularly important for individuals with MTHFR polymorphisms who cannot efficiently convert folic acid to its active form. Clinical evidence strongly supports its role in lowering plasma homocysteine.

  • CarbúnculosCientífico

    5-Methyltetrahydrofolate (5-MTHF) is the active circulating form of folate used directly in one-carbon metabolism for RBC synthesis. It is particularly relevant for individuals with MTHFR polymorphisms who cannot efficiently convert folic acid, and corrects folate-related anemia and fatigue.

  • Methylfolate (5-MTHF) is the biologically active, directly usable form of folate that crosses the blood-brain barrier. It supports neurotransmitter synthesis, DNA methylation, and homocysteine reduction. It is particularly beneficial for individuals with MTHFR gene variants who cannot efficiently convert folic acid to active folate, and RCT evidence supports its role in cognitive performance.

  • EscalofríosCientífico

    5-Methyltetrahydrofolate (5-MTHF) is the bioactive form of folate that crosses the blood-brain barrier to support one-carbon metabolism, neurotransmitter synthesis, and homocysteine regulation critical for memory. It is particularly relevant for individuals with MTHFR gene polymorphisms who cannot efficiently convert folic acid. Evidence for memory improvement parallels that of folate supplementation in older adults with elevated homocysteine.

  • 5-Methyltetrahydrofolate (5-MTHF) is the bioactive form of folate, directly bioavailable even in individuals with MTHFR polymorphisms. It supports neurotransmitter synthesis and cognitive function, and is used clinically to support mental energy and clarity.

  • 5-Methyltetrahydrofolate (5-MTHF) is the bioactive folate form that donates its methyl group to homocysteine (via methionine synthase/B12) to regenerate methionine and sustain SAMe production. Particularly important for individuals with MTHFR gene variants, clinical RCTs demonstrate significant homocysteine reduction with 5-MTHF supplementation.

  • 5-Methyltetrahydrofolate (5-MTHF) is the biologically active form of folate that supports mitochondrial one-carbon metabolism and de novo purine nucleotide synthesis. It is used in mitochondrial disorder protocols and is particularly relevant for individuals with MTHFR polymorphisms who cannot convert folic acid to the active mitochondrially-available form.

  • Methylfolate (5-MTHF) is the active, blood-brain barrier-crossing form of folate that directly supports neurotransmitter synthesis, methylation reactions, and homocysteine metabolism in the nervous system. It is particularly important for individuals with MTHFR polymorphisms who cannot efficiently convert folic acid.

  • ColitisCientífico

    5-MTHF is the biologically active folate form that directly regenerates SAMe, supporting serotonin, dopamine, and norepinephrine synthesis. Clinical RCTs demonstrate adjunctive 15 mg/day L-methylfolate significantly improves treatment-resistant depression. It bypasses MTHFR polymorphisms affecting 25–40% of the population.

  • Methylfolate (5-MTHF) is the bioavailable form of folate that bypasses the MTHFR conversion step. Given the high prevalence of MTHFR polymorphisms in PCOS-associated populations and folate's role in homocysteine reduction and reproductive health, methylfolate is specifically relevant for PCOS women with impaired folate metabolism.

  • Methylfolate (5-MTHF) is the bioactive form of folate used in pediatric supplements targeting picky eaters with documented folate deficiency. It bypasses the MTHFR conversion step and is especially relevant for children with MTHFR gene polymorphisms. Its use mirrors the documented folate gap in picky eating children.

  • ConjuntivitisCientífico

    5-methyltetrahydrofolate (5-MTHF) is the bioactive, directly usable form of folate that bypasses the MTHFR genetic polymorphism. It is the preferred supplemental form for post-illness recovery of immune cell function, red blood cell production, and methylation reactions critical to cellular restoration.

  • 5-Methyltetrahydrofolate (5-MTHF) is the bioactive form of folate that bypasses MTHFR enzyme conversion, making it directly available for one-carbon metabolism, homocysteine clearance, and DNA methylation. It is preferred in post-viral recovery protocols for patients with MTHFR polymorphisms, who are overrepresented in post-viral fatigue populations.

  • ConvalecenciaCientífico

    The active methylated form of folate (5-MTHF) supports red blood cell production, tissue repair, and DNA synthesis postpartum and is especially relevant for women with MTHFR polymorphisms who cannot efficiently convert folic acid. It is actively secreted into breast milk, raising maternal requirements. NIH ODS and clinical guidelines identify folate as a key postpartum nutrient.

  • ConvulsionesCientífico

    5-Methyltetrahydrofolate (5-MTHF) is the biologically active circulating form of folate used in prenatal supplements, especially for women with MTHFR gene variants that reduce folic acid conversion efficiency. Clinical trials show it effectively raises serum folate levels. EU and several national health authorities have approved 5-MTHF as a bioequivalent alternative to folic acid for NTD risk reduction during pregnancy.

  • FiebreTradicional

    5-methyltetrahydrofolate (5-MTHF) is the bioactive form of folate required for one-carbon metabolism and DNA synthesis in hair matrix cells. It is preferentially used in individuals with MTHFR polymorphisms who have impaired conversion of folic acid. The same evidence base supporting folate's role in hair loss applies to this more bioavailable form.

Sistemas Corporales

Sistemas corporales que Vitamin B9 (methylfolate/5-MTHF) puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada